Danaher Corporation (DHR) Interest Coverage Ratio: 19.38x
The interest coverage ratio for Danaher Corporation (DHR) is 19.38x as of Wednesday, June 17, 2026.
DHR Interest Coverage Ratio Metrics
INTEREST COVERAGE RATIO
19.38x
DHR Competitors' Interest Coverage Ratio
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Danaher Corporation (DHR) | $128.06B | 19.38x | N/A | N/A | N/A |
| CVS Health Corporation (CVS)vs › | $127.73B | 3.33x | 3.10x | 3.72x | 4.16x |
| Stryker Corporation (SYK)vs › | $119.06B | 8.05x | 10.41x | 10.98x | 10.79x |
| Vertex Pharmaceuticals Incorporated (VRTX)vs › | $115.02B | 357.95x | 357.95x | 174.48x | 123.56x |
| Bristol-Myers Squibb Company (BMY)vs › | $114.19B | 8.41x | 6.69x | 7.04x | 6.41x |
| Intuitive Surgical, Inc. (ISRG)vs › | $145.70B | N/A | 55.58x | 55.58x | 55.58x |
| Pfizer Inc. (PFE)vs › | $148.41B | 5.78x | 5.55x | 10.96x | 11.04x |
| Medtronic plc (MDT)vs › | $103.29B | 9.04x | 8.61x | 8.24x | 8.04x |
| Abbott Laboratories (ABT)vs › | $157.84B | 23.60x | 17.46x | 17.67x | 16.77x |
| Gilead Sciences, Inc. (GILD)vs › | $158.06B | 11.43x | 6.56x | 7.26x | 7.18x |
Financial Health Indicators
Interest Coverage
19.4x
Debt/Equity
0.35
Current Ratio
1.87
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
- < 1.5x: EBIT is less than 1.5 times interest expense
- 1.5x - 3x: EBIT is between 1.5 and 3 times interest expense
- 3x - 5x: EBIT is between 3 and 5 times interest expense
- > 5x: EBIT is more than 5 times interest expense
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Danaher Corporation Interest Coverage Ratio Formula & Definition
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Danaher Corporation Interest Coverage Ratio FAQ
- What is the interest coverage ratio for Danaher Corporation (DHR)?
- The interest coverage ratio for DHR stock is 19.38x.
About Danaher Corporation
Danaher Corporation is a diversified global technology and science company that specializes in developing, manufacturing, and distributing a wide array of professional, medical, industrial, and commercial products and services across the world. The organization is structured into three primary operating segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. Within the Life Sciences segment, Danaher provides advanced instrumentation and solutions crucial for scientific research and development. This encompasses equipment like mass spectrometers, flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization tools, and microscopes, alongside genomics consumables and technologies vital for Gene and Cell Therapy. Additionally, it delivers bioprocess technologies, consumables, and related services, as well as sophisticated filtration, separation, and purification systems. Its diverse clientele includes pharmaceutical, biopharmaceutical, food and beverage, medical, and life sciences companies, in addition to universities, medical schools, research institutions, and various industrial manufacturers. The Diagnostics segment is dedicated to furnishing essential tools for healthcare. Its offerings range from comprehensive systems for chemistry, immunoassay, microbiology, and automation to products for hematology, molecular, acute care, and pathology diagnostics. This segment equips hospitals, physicians' offices, reference laboratories, and other critical care settings with clinical instruments, reagents, consumables, software, and support services for accurate patient diagnosis and management. The Environmental & Applied Solutions segment addresses a broad spectrum of industrial and resource management requirements. It supplies instrumentation, consumables, software, services, and disinfection systems critical for the analysis, treatment, and management of various water types—including ultra-pure, potable, industrial, waste, ground, source, and ocean water—across residential, commercial, industrial, and natural resource applications. Furthermore, this segment delivers instruments, software, services, and consumables tailored for color and appearance management, packaging design and quality assurance, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. Established in 1969, the company was initially known as Diversified Mortgage Investors, Inc., before officially rebranding as Danaher Corporation in 1984. Its corporate headquarters are located in Washington, D.C.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Rainer Blair